Language session
Chinese Programme 2022
COVID
A joint ERS/CTS session
Aims : To present and discuss the new advances in respiratory medicine presented by experienced speakers from the European Respiratory Society leadership and Chinese leaders in respiratory medicine; to present an overview of hot respiratory disease topics in Europe and China.
This session will be delivered in English and will not be translated in Chinese.
Target audience :
Adult pulmonologist/Clinician, Clinical researcher, General practitioner, Medical Student, Medical Technical Assistant, Respiratory critical care physician, Pathologist, Physician in Pulmonary Training, Physiologist, Respiratory physiotherapist, Scientist (basic, translational), Thoracic oncologist, Thoracic surgeon, Respiratory therapist
Methods :
Epidemiology, Public health, Respiratory intensive care
09:30
Early interventions of lung cancer
N. Zhong(Guangzhou (Guangdong), China)
COI
-
Description
1
3627
09:45
Status and future perspective of biomarkers in early detection of lung cancer
T. Blum(Berlin, Germany)
COI
2
3628
10:00
Clinical progress in critical care of pulmonary medicine in China
L. Xie(Beijing, China)
COI
-
Description
3
3629
10:15
New insights in the pathophysiology of ARDS
L. Bos(Amsterdam, Netherlands)
COI
4
3630
10:30
Discussion and Q&A
5
3631
. . .
